4472-05-3Relevant articles and documents
Novel compounds and methods for synthesis and therapy
-
, (2008/06/13)
Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.
CARBOCYCLIC COMPOUNDS
-
, (2008/06/13)
Novel carbocyclic compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.
Compounds containing fluorocarbon residues and azido groups as textile-finishing agents
-
, (2008/06/13)
Textile-finishing agents are provided by compounds of the formula wherein Rf represents a fluorocarbon chain, A represents a linking group, X represents a sulphonazide or azidoformate group and m and n are integers. The Rf group may be a linear or branched fluorocarbon chain containing 2 to 12 carbon atoms, and the linking group A may be a simple organic linking group or it may be a macromolecular linking group. The simple linking groups may have one or more fluorocarbon chains and one or more azido groups attached thereto, while the macromolecular linking groups may have a considerable number of fluorocarbon and/or azido groups attached thereto.